A detailed history of Commonwealth Equity Services, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 15,491 shares of VRNA stock, worth $701,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,491
Holding current value
$701,432
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$15.46 - $30.16 $239,490 - $467,208
15,491 New
15,491 $446,000
Q2 2023

Aug 10, 2023

SELL
$19.41 - $23.43 $227,659 - $274,810
-11,729 Reduced 49.51%
11,960 $253,000
Q1 2023

May 11, 2023

BUY
$18.06 - $25.27 $201,910 - $282,518
11,180 Added 89.38%
23,689 $475,000
Q4 2022

Feb 07, 2023

BUY
$9.84 - $26.13 $123,088 - $326,860
12,509 New
12,509 $326,000

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.76B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.